Hitarth Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -70.03%
- Profit Growth -91.80%
- Ebitda -20.06%
- Net Worth 6.85%
- Total Assets -8.68%
About Hitarth Biotech
Hitarth Biotech Private Limited (HBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 December 2017 (Seven years and one month 8 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Om Golechha, Arun Dhariwal, and Niyati serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304KA2017PTC108938
-
Company No.
108938
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2017
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Hitarth Biotech Private Limited offer?
Hitarth Biotech Private Limited offers a wide range of products and services, including Viscose & Rayon Fabric, Printed Rayon Fabric.
Who are the key members and board of directors at Hitarth Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Om Golechha
|
Director | 26-Dec-2017 | Current |
|
Arun Dhariwal
|
Director | 26-Dec-2017 | Current |
|
Niyati
|
Director | 26-Dec-2017 | Current |
Financial Performance of Hitarth Biotech.
Hitarth Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 70.03% decrease. The company also saw a substantial fall in profitability, with a 91.8% decrease in profit. The company's net worth moved up by a moderate rise of 6.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hitarth Biotech?
In 2020, Hitarth Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hitarth Biotech?
Unlock and access historical data on people associated with Hitarth Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hitarth Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hitarth Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.